Get the Stockscreener App
9.68
0.31%
-0.03
After Hours:
9.70
0.02
+0.21%
Brainsway Ltd Adr stock is traded at $9.68, with a volume of 22,976.
It is down -0.31% in the last 24 hours and up +0.31% over the past month.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
See More
Previous Close:
$9.71
Open:
$9.72
24h Volume:
22,976
Relative Volume:
0.26
Market Cap:
$182.38M
Revenue:
$38.63M
Net Income/Loss:
$1.50M
P/E Ratio:
-12.41
EPS:
-0.78
Net Cash Flow:
$5.97M
1W Performance:
-1.53%
1M Performance:
+0.31%
6M Performance:
+79.26%
1Y Performance:
+60.53%
1-Day Range:
$9.56
$9.79
1-Week Range:
$9.5274
$10.29
52-Week Range:
$4.61
$10.98
Brainsway Ltd Adr Stock (BWAY) Company Profile
Compare BWAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BWAY
Brainsway Ltd Adr
|
9.68 | 182.38M | 38.63M | 1.50M | 5.97M | -0.78 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-16-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-03-22 | Initiated | Loop Capital | Buy |
| Jul-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-20-21 | Initiated | Northland Capital | Outperform |
| May-13-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-13-19 | Initiated | Ladenburg Thalmann | Buy |
| May-13-19 | Initiated | Oppenheimer | Outperform |
| May-13-19 | Initiated | Raymond James | Outperform |
View All
Brainsway Ltd Adr Stock (BWAY) Latest News
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy - GlobeNewswire Inc.
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
Brainsway stock soars to 52-week high, hits $10.75 - Investing.com
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024 - Yahoo Finance
Brainsway LtdADR (BWAY) Price Target Increased by 16.24% to 0.07 - MSN
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade - MSN
Here's Why Momentum in Brainsway (BWAY) Should Keep going - MSN
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Are Medical Stocks Lagging Brainsway (BWAY) This Year? - MSN
Brainsway stock soars to 52-week high, hits $10.01 - Investing.com
BrainsWay expands mental health treatment in East Asia - Investing.com India
Brainsway Stock Hits 52-Week High at $9.72 Amidst 143% Annual Surge - Investing.com
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Does Brainsway (BWAY) Have the Potential to Rally 34.38% as Wall Street Analysts Expect? - MSN
Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock? - Yahoo Finance
BrainsWay secures $20 million in private investment By Investing.com - Investing.com
Zacks.com featured highlights include Byrna Technologies, Idaho Strategic Resources, Limbach Holdings, Sezzle and BrainsWay - Yahoo Finance
Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why - Nasdaq
5 Stocks With Recent Price Strength to Enhance Your Portfolio - Yahoo Finance
Here's Why Brainsway Ltd. Sponsored ADR (BWAY) is a Great Momentum Stock to Buy - MSN
New additions to Roth MKM’s ADR portfolio for September - MSN
Brainsway stock soars to 52-week high, hits $8.29 - Investing.com
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Mexico Transcranial Magnetic Stimulation System Market Size & Outlook, 2030 - Grand View Research
The Zacks Analyst Blog Fulcrum Therapeutics, Heritage Insurance, Latham Group, Seanergy Maritime and BrainsWay - Yahoo Finance
Wall Street Analysts See a 60.85% Upside in Brainsway (BWAY): Can the Stock Really Move This High? - Yahoo Finance
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue? - MSN
Why Brainsway (BWAY) Might be Well Poised for a Surge - MSN
Wall Street Analysts Think Brainsway (BWAY) Could Surge 72.29%: Read This Before Placing a Bet - Yahoo Finance
Brainsway Ltd Adr Stock (BWAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):